1. Home
  2. GLW vs VRTX Comparison

GLW vs VRTX Comparison

Compare GLW & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corning Incorporated

GLW

Corning Incorporated

HOLD

Current Price

$179.75

Market Cap

149.7B

Sector

Industrials

ML Signal

HOLD

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$445.47

Market Cap

115.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLW
VRTX
Founded
1851
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
EDP Services
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
149.7B
115.7B
IPO Year
2008
2006

Fundamental Metrics

Financial Performance
Metric
GLW
VRTX
Price
$179.75
$445.47
Analyst Decision
Buy
Buy
Analyst Count
12
29
Target Price
$146.91
$539.69
AVG Volume (30 Days)
10.0M
1.1M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
0.74%
N/A
EPS Growth
215.52
836.54
EPS
0.43
4.02
Revenue
$15,629,000,000.00
$2,488,652,000.00
Revenue This Year
$20.74
$10.79
Revenue Next Year
$12.80
$10.47
P/E Ratio
$412.05
$110.19
Revenue Growth
19.14
46.20
52 Week Low
$49.81
$362.50
52 Week High
$211.79
$509.98

Technical Indicators

Market Signals
Indicator
GLW
VRTX
Relative Strength Index (RSI) 49.28 54.00
Support Level $171.11 $429.02
Resistance Level $210.18 $449.97
Average True Range (ATR) 12.05 10.07
MACD -2.66 0.69
Stochastic Oscillator 33.57 75.17

Price Performance

Historical Comparison
GLW
VRTX

About GLW Corning Incorporated

Corning is a provider of glass, ceramics, and optical fiber across six distinct end markets. Corning's largest segments by revenue are display glass for TVs and optical fiber for telecom networks and data centers. It also provides cover glass for smartphones as well as filters and substrates and glass for cars, produces pharmaceutical glass, and produces polysilicon for solar panels. Corning is a US producer and is vertically integrated across its products and markets.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: